000 01235 a2200325 4500
005 20250514033904.0
264 0 _c20020701
008 200207s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood-2002-02-0624
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDevine, Steven M
245 0 0 _aReduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
_h[electronic resource]
260 _bBlood
_cJun 2002
300 _a4251-2; author reply 4252 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aCombined Modality Therapy
650 0 4 _aHematopoietic Stem Cell Transplantation
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMelphalan
_xtherapeutic use
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aNeutropenia
_xprevention & control
650 0 4 _aThrombocytopenia
_xprevention & control
650 0 4 _aTransplantation, Autologous
650 0 4 _aWhole-Body Irradiation
700 1 _aJahagirdar, Balkrishna
700 1 _avan Besien, Koen
773 0 _tBlood
_gvol. 99
_gno. 11
_gp. 4251-2; author reply 4252
856 4 0 _uhttps://doi.org/10.1182/blood-2002-02-0624
_zAvailable from publisher's website
999 _c11940365
_d11940365